Corteva Catalyst

Corteva Catalyst is the venture and innovation investment arm of Corteva Agriscience, one of the worlds largest agricultural chemicals and seeds companies spun out of DowDuPont in 2019. Corteva Catalyst co-led the $105m Series B fundraise for Tropic Biosciences alongside Forbion and other investors, giving the Norwich-based gene-editing company backing from an industry strategic that has both the capital and the commercial distribution to help take crop traits to market at scale.

Corteva Agriscience is headquartered in Indianapolis and has annual revenues of approximately $17bn, with operations spanning herbicides, fungicides, insecticides, and proprietary seed genetics. Corteva Catalyst sits within this structure as the early-stage technology scouting and investing arm, backing companies working on crop improvement, precision agriculture, and biological crop protection. Strategic investment from Corteva brings more than capital: it provides access to global regulatory expertise, field trial infrastructure, and agricultural distribution channels across dozens of markets.

For Tropic Biosciences, Corteva Catalysts involvement signals that the company has cleared a strategic validation threshold that purely financial investors cannot provide. Large agrochemical companies invest strategically in gene-editing companies partly to build acquisition options, and partly to ensure they are positioned alongside the technology if it disrupts their core seed genetics business.